title: An association between increased concentrations of cerebrospinal fluid dopamine sulfate and higher negative symptom scores in patients with schizophrenia and schizoaffective disorder.
authors.affiliation: Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322.
authors.forename: E D
authors.initials: ED
authors.lastname: Risby
authors.forename: R D
authors.initials: RD
authors.lastname: Jewart
authors.forename: R R
authors.initials: RR
authors.lastname: Lewine
authors.forename: S C
authors.initials: SC
authors.lastname: Risch
authors.forename: M
authors.initials: M
authors.lastname: Stipetic
authors.forename: J S
authors.initials: JS
authors.lastname: McDaniel
authors.forename: J
authors.initials: J
authors.lastname: Caudle
mesh_terms: D002908:Chronic Disease; D004298:Dopamine / Q000031:analogs & derivatives* / Q000134:cerebrospinal fluid / Q000502:physiology; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000134:cerebrospinal fluid* / Q000523:psychology; D012016:Reference Values; D012559:Schizophrenia / Q000134:cerebrospinal fluid*; D012565:Schizophrenic Psychology
chemical_list: C022807:dopamine 4-O-sulfate; D004298:Dopamine; D006719:Homovanillic Acid